Sequential mavacamten therapy and TAVRtavr in an elderly patient with concomitant severe aortic stenosis and obstructive hypertrophic cardiomyopathy

30 August 2026 (17:36 - 17:48)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Yihang Wu

Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)

4 More presentations in this session

Presentation thumbnail

Transcatheter aortic valve implantation under extracorporeal membrane oxygenation in a patient with cardiogenic shock due to a degenerated bioprosthesis

Doctor M. Rodrigues (Rio de Janeiro, BR)

Presentation thumbnail

Mid-term outcomes after staged transcatheter management of severe native aortic regurgitation and cardiac resynchronisation therapy in a high-risk patient

Doctor T. Camuz (Istanbul, TR)

Presentation thumbnail

Navigating the perfect storm: Cardiac Arrest, AMA, and redo TAVI.

Doctor R. Alotaibi (Riyadh, SA)

Presentation thumbnail

Between a rock and a hard place

Doctor R. Murray (Kuala Lumpur, MY)

Access the full session

Session thumbnail

Transcatheter aortic valve implantation in challenging clinical scenarios

The Event

Event poster

ESC Congress 2026

30 August 2026 17:36 CET

You may be interested in

Congress Presentation

Mavacamten therapy in hypertrophic obstructive cardiomyopathy revealing severe aortic stenosis: a case highlighting diagnostic complexity

11 May 2026

Congress Presentation

The evolution of the obstructive HCM therapeutic landscape: emerging evidence about cardiac myosin inhibitors

31 August 2025

Congress Presentation

Mitral regurgitation in obstructive hypertrophic cardiomyopathy: assessing the impact of mavacamten

13 December 2024

Congress Session

Taking a deeper dive in cardiomyopathies

19 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources